COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,646 Articles (22,913 medRxiv, 8,733 bioRxiv)

Most recent first Previous |  Page 1668: Articles 16671-16680  | Next

North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness.
Glampson, B., Brittain, J., Kaura, A., Mulla, A., Mercuri, L., Brett, S., Aylin, P., Sandall, T., Goodman, I., Redhead, J., Saravanakumar, K., Mayer, E.
10.1101/2021.04.08.21254580 — Posted: 2021-04-10
Atypical N-glycosylation of SARS-CoV-2 impairs the efficient binding of Spike-RBM to the human-host receptor hACE2
Gamez, G., Hermoso, J. A., Carrasco-Lopez, C., Gomez Mejia, A., Muskus, C., Hammerschmidt, S.
10.1101/2021.04.09.439154 — Posted: 2021-04-10
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
King, H. A. D., Joyce, M. G., Elakhal Naouar, I., Ahmed, A., Macedo Cincotta, C., Subra, C., Peachman, K. K., Hack, H. H., Chen, R. E., Thomas, P. V., Chen, W.-H., Sankhala, R. S., Hajduczki, A., Martinez, E. J., Peterson, C. E., Chang, W. C., Choe, M., Smith, C., Headley, J. A., Elyard, H. A., Cook, A., Anderson, A., Wuertz, K. M., Dong, M., Swafford, I., Case, J. B., Currier, J. R., Lal, K. G., Amare, M. F., Dussupt, V., Molnar, S., Daye, S. P., Zeng, X., Barkei, E. K., Alfson, K., Staples, H. M., Carrion, R., Krebs, S. J., Paquin-Proulx, D., Karasavvas, N., Polonis, V. R., Jagodzinski, L. L., Vasan, S., Scott, P. T., Huang, Y., Nair, M. S., Ho, D. D., de Val, N., Diamond, M. S., Lewis, M. G., Rao, M., Matyas, G. R., Gromowski, G. D., Peel, S. A., Michael, N. L., Modjarrad, K., Bolton, D. L.
10.1101/2021.04.09.439166 — Posted: 2021-04-10
Large fluctuations of the fusion intermediate help SARS-CoV-2 capture host cell membranes
Su, R., Zeng, J., O'Shaughnessy, B.
10.1101/2021.04.09.439051 — Posted: 2021-04-10
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300
Davis, D. A., Bulut, H., Shrestha, P., Yaparla, A., Jaeger, H. K., Hattori, S.-i., Wingfield, P., Mitsuya, H., Yarchoan, R.
10.1101/2021.04.09.439169 — Posted: 2021-04-10
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2
Mast, F. D., Fridy, P. C., Ketaren, N. E., Wang, J., Jacobs, E. Y., Olivier, J. P., Sanyal, T., Molloy, K. R., Schmidt, F., Rutkowska, M., Weisblum, Y., Rich, L. M., Vanderwall, E. R., Dambrauskas, N., Vigdorovich, V., Keegan, S., Jiler, J. B., Stein, M. E., Olinares, P. D. B., Hatziioannou, T., Sather, D. N., Debley, J. S., Fenyö, D., Sali, A., Bieniasz, P. D., Aitchison, J. D., Chait, B. T., Rout, M. P.
10.1101/2021.04.08.438911 — Posted: 2021-04-10
A trimeric hydrophobic zipper mediates the intramembrane assembly of SARS-CoV-2 spike
Fu, Q., Chou, J. J.
10.1101/2021.04.09.439203 — Posted: 2021-04-10
The homology analysis of ACE2 gene and its distinct expression in laboratory and wild animals
Wang, G., A-Mei, Z., Binghui, W., Yin, J., Yue, F., Baloch, Z., Xia, X.-s.
10.1101/2021.04.08.439088 — Posted: 2021-04-10
Theoretical causes of the Brazilian P.1 and P.2 lineages of the SARS-CoV-2 virus through molecular dynamics
Lima de Oliveira, M. D., Teixeira de Oliveira, K. M., Nunes da Silva, J., Santos, C., Bessa, J., de Freitas Rodrigues, R.
10.1101/2021.04.09.439181 — Posted: 2021-04-10
Exploring zebrafish larvae as a COVID-19 model: probable SARS-COV-2 replication in the swim bladder
Laghi, V., Rezelj, V., Boucontet, L., Boudinot, P., Salinas, I., Lutfalla, G., Vignuzzi, M., Levraud, J.-P.
10.1101/2021.04.08.439059 — Posted: 2021-04-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).